Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2018

Mar 24, 2023

BUY
$3.83 - $5.92 $402 - $621
105 New
105 $403,000
Q2 2018

Mar 24, 2023

BUY
$4.56 - $7.83 $478 - $822
105 New
105 $563,000

Others Institutions Holding ONCY

About ONCOLYTICS BIOTECH INC


  • Ticker ONCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 57,867,400
  • Market Cap $46.9M
  • Description
  • Oncolytics Biotech Inc., a development-stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. Its lead product is pelareorep, an intravenously delivered immunotherapeutic agent for the treatment of solid tumors and hematological malignancies. Oncolytics Biotech Inc. has a...
More about ONCY
Track This Portfolio

Track American Portfolios Advisors Portfolio

Follow American Portfolios Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Portfolios Advisors, based on Form 13F filings with the SEC.

News

Stay updated on American Portfolios Advisors with notifications on news.